Teleflex Incorporated (NYSE:TFX) Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $248.96, for a total transaction of $49,792.00. Following the transaction, the director now owns 8,080 shares of the company’s stock, valued at $2,011,596.80. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Teleflex Incorporated (NYSE:TFX) traded up $1.91 on Thursday, hitting $256.64. 188,000 shares of the company traded hands, compared to its average volume of 246,200. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70. Teleflex Incorporated has a twelve month low of $159.64 and a twelve month high of $271.23. The firm has a market capitalization of $11,475.40, a PE ratio of 46.83, a PEG ratio of 1.88 and a beta of 1.09.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.01 by $0.11. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The business had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same period last year, the company earned $1.80 earnings per share. The company’s quarterly revenue was up 17.3% on a year-over-year basis. research analysts expect that Teleflex Incorporated will post 8.35 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, December 15th. Investors of record on Wednesday, November 15th were given a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 0.53%. Teleflex’s dividend payout ratio is presently 24.82%.
Several equities analysts have weighed in on TFX shares. KeyCorp restated a “hold” rating on shares of Teleflex in a report on Wednesday, September 6th. Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $220.00 to $274.00 in a report on Wednesday, September 6th. Leerink Swann upgraded shares of Teleflex from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $227.00 to $266.00 in a report on Thursday, September 7th. Jefferies Group lifted their price target on shares of Teleflex from $253.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, September 8th. Finally, Zacks Investment Research downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, September 9th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $274.44.
Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Victory Capital Management Inc. boosted its position in shares of Teleflex by 21.0% in the second quarter. Victory Capital Management Inc. now owns 7,325 shares of the medical technology company’s stock worth $1,522,000 after acquiring an additional 1,269 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in Teleflex by 120.6% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,496 shares of the medical technology company’s stock valued at $310,000 after buying an additional 818 shares in the last quarter. Neuberger Berman Group LLC lifted its position in Teleflex by 0.5% during the second quarter. Neuberger Berman Group LLC now owns 5,708 shares of the medical technology company’s stock valued at $1,186,000 after buying an additional 28 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Teleflex by 21.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,235 shares of the medical technology company’s stock valued at $1,503,000 after buying an additional 1,286 shares in the last quarter. Finally, Commerce Bank acquired a new position in Teleflex during the second quarter valued at approximately $400,000. 88.97% of the stock is currently owned by institutional investors and hedge funds.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.